Menu
Back to Journals » OncoTargets and Therapy » Volume 16
OncoTargets and Therapy
ISSN: 1178-6930
- View all (6490)
- Volume 17, 2024 (52)
- Volume 16, 2023 (147)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Archive: Volume 16, 2023
The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer [Retraction]
Chen Y, Lei Y, Lin J, Huang Y, Zhang J, Chen K, Sun S, Lin X
OncoTargets and Therapy 2023, 16:1073-1074
Published Date: 24 December 2023
Inhibition of ATM with KU-55933 Sensitizes Endometrial Cancer Cell Lines to Olaparib
Zhang A, Zhang L, Xie X, Liu D
OncoTargets and Therapy 2023, 16:1061-1071
Published Date: 19 December 2023
Post-HSCT Maintenance Treatment Using Entrectinib for an AML Patient Accompanied with ETV6::NTRK3: A Case Report
Zhao X, Hao M, Zhang X, Wei J, Feng S, He Y, Jiang E, Han M
OncoTargets and Therapy 2023, 16:1055-1059
Published Date: 18 December 2023
ST6GAL2 Downregulation Inhibits Cell Adhesion and Invasion and is Associated with Improved Patient Survival in Breast Cancer [Retraction]
Cheng J, Wang R, Zhong G, Chen X, Cheng Y, Li W, Yang Y
OncoTargets and Therapy 2023, 16:1053-1054
Published Date: 15 December 2023
MLPH Accelerates the Epithelial–Mesenchymal Transition in Prostate Cancer [Retraction]
Zhang T, Sun Y, Zheng T, Wang R, Jia D, Zhang W
OncoTargets and Therapy 2023, 16:1051-1052
Published Date: 15 December 2023
Epithelioid Subtype Gastrointestinal Stromal Tumors of Stomach in an Endoscopic Biopsy: A Potential Diagnostic Pitfall
Xu W, Tang H, Chen Y, Wang J, Chen Z, Xu Y, Guo D
OncoTargets and Therapy 2023, 16:1043-1049
Published Date: 12 December 2023
Investigating the Diagnostic and Therapeutic Potential of SREBF2-Related Lipid Metabolism Genes in Colon Cancer
Ma Y, Wang Z, Sun J, Tang J, Zhou J, Dong M
OncoTargets and Therapy 2023, 16:1027-1042
Published Date: 11 December 2023
miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia [Retraction]
Wang D, Chen J, Ding Y, Kong H, You H, Zhao Y, Wei H, Liu Y
OncoTargets and Therapy 2023, 16:1025-1026
Published Date: 7 December 2023
MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression by Targeting PDK1/PI3K/AKT Pathway [Retraction]
Wei Y, Liao Y, Deng Y, Zu Y, Zhao B, Li F
OncoTargets and Therapy 2023, 16:1023-1024
Published Date: 7 December 2023
Hsa_circ_0008945 Promoted Breast Cancer Progression by Targeting miR-338-3p [Retraction]
Zhang L, Ding F
OncoTargets and Therapy 2023, 16:1021-1022
Published Date: 1 December 2023
Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer
Huang Y, Dai S, Yin W, Luo F, Li Y
OncoTargets and Therapy 2023, 16:1015-1020
Published Date: 29 November 2023
LncRNA FTX Promotes Proliferation and Invasion of Gastric Cancer via miR-144/ZFX Axis [Retraction]
Li H, Yao G, Zhai J, Hu D, Fan Y
OncoTargets and Therapy 2023, 16:1013-1014
Published Date: 28 November 2023
Optimizing the Continuum of Care in Gastric Cancer
Riccò B, Martinelli G, Bardasi C, Dominici M, Spallanzani A, Salati M
OncoTargets and Therapy 2023, 16:995-1012
Published Date: 23 November 2023
Anti-Glioma Effects of Ligustilide or n-Butylphthalide on Their Own and the Synergistic Effects with Temozolomide via PI3K/Akt Signaling Pathway
Li ZQ, Zhang GS, Liu RQ, Shuai SY, Hu PY, Zheng Q, Xiao SH
OncoTargets and Therapy 2023, 16:983-994
Published Date: 22 November 2023
Cancer and the Vasopressin Gene: Radioimmunoassay Values and Commentary on Copeptin as a Plasma Marker
North WG
OncoTargets and Therapy 2023, 16:973-982
Published Date: 20 November 2023
Oral Anlotinib Maintenance Therapy for an Advanced Malignant Peritoneal Mesothelioma Diagnosed by Laparoscopy After Initial Misdiagnosis to Obtain Longer Progression-Free Survival: Case Report and Literature Review
Qu FJ, Zhou Y, Wang H
OncoTargets and Therapy 2023, 16:961-972
Published Date: 15 November 2023
Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study
Zhou Y, Guo X, Shen L, Liu K, Sun Q, Wang Y, Wang H, Fu W, Yao Y, Wu S, Chen H, Qiu J, Pan T, Deng Y
OncoTargets and Therapy 2023, 16:939-960
Published Date: 16 November 2023
miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer [Retraction]
Wang J, Wang L, Zhang C
OncoTargets and Therapy 2023, 16:937-938
Published Date: 10 November 2023
Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer: A Real-World, Single-Center Study
Chen Z, He Y, Ding C, Chen J, Gu Y, Xiao M, Li Q
OncoTargets and Therapy 2023, 16:923-935
Published Date: 9 November 2023
GW4869 Can Inhibit Epithelial-Mesenchymal Transition and Extracellular HSP90α in Gefitinib-Sensitive NSCLC Cells
Wan X, Fang Y, Du J, Cai S, Dong H
OncoTargets and Therapy 2023, 16:913-922
Published Date: 8 November 2023
Successful Treatment of Concurrent Follicular Lymphoma and Triple-Negative Breast Cancer Using Rituximab Plus Nab-Paclitaxel and Cisplatin: A Case Report and Literature Review
Zhu Z, Zhou N, Yu S, Gao X, Cheng X, Wang Y, Bai C
OncoTargets and Therapy 2023, 16:905-911
Published Date: 1 November 2023
Galectin-9 Expression is Correlated to Cervical Squamous Cell Carcinoma Progression and Overall Survival
Mendieta-Carmona V, Delgado-López G, Reyes-Leyva J, Gutiérrez-Quiroz CT, Vazquez-Zamora VJ, Picazo-Mendoza DA, Montiel-Jarquín AJ, Martinez-Morales LP, Vallejo-Ruiz V
OncoTargets and Therapy 2023, 16:891-904
Published Date: 31 October 2023
Immunotherapy Combined with Chemotherapy in Relapse Metaplastic Breast Cancer
Chen L, Meng Z, Zhou Z, Li X, Zhao L, Jia Z, Chen J, Tian Y, Meng Q, Liu Y
OncoTargets and Therapy 2023, 16:885-890
Published Date: 30 October 2023
B7 Induces Apoptosis in Colorectal Cancer Cells by Regulating the Expression of Caspase-3 and Inhibits Autophagy
Zhang X, Li F, Li R, Zhao N, Liu D, Xu Y, Wang L, Wang D, Zhao R
OncoTargets and Therapy 2023, 16:867-883
Published Date: 27 October 2023
HOXC Cluster Antisense RNA 3, a Novel Long Non-Coding RNA as an Oncological Biomarker and Therapeutic Target in Human Malignancies
Xie Y, Ye J, Luo H
OncoTargets and Therapy 2023, 16:849-865
Published Date: 24 October 2023
LncRNA SNHG7 Functions as an Oncogene in Cervical Cancer by Sponging miR-485-5p to Modulate JUND Expression [Retraction]
Zhao D, Zhang H, Long J, Li M
OncoTargets and Therapy 2023, 16:847-848
Published Date: 20 October 2023
LncRNA EWSAT1 Promotes Colorectal Cancer Progression Through Sponging miR-326 to Modulate FBXL20 Expression [Retraction]
Liu J, Huang S, Liao X, Chen Z, Li L, Yu L, Zhan W, Li R
OncoTargets and Therapy 2023, 16:845-846
Published Date: 20 October 2023
Long Non-Coding RNA LEF1-AS1 Promotes Migration, Invasion and Metastasis of Colon Cancer Cells Through miR-30-5p/SOX9 Axis [Retraction]
Sun T, Liu Z, Zhang R, Ma S, Lin T, Li Y, Yang S, Zhang W, Wang Y
OncoTargets and Therapy 2023, 16:843-844
Published Date: 20 October 2023
MicroRNA-188-5p Promotes Epithelial–Mesenchymal Transition by Targeting ID4 Through Wnt/β-Catenin Signaling in Retinoblastoma [Retraction]
Yang M, Li Y, Wei W
OncoTargets and Therapy 2023, 16:841-842
Published Date: 20 October 2023
Identification of Osteosarcoma Metastasis-Associated Gene Biomarkers and Potentially Targeted Drugs Based on Bioinformatic and Experimental Analysis [Retraction]
Cao MD, Song YC, Yang ZM, Wang DW, Lin YM, Lu HD
OncoTargets and Therapy 2023, 16:839-840
Published Date: 20 October 2023
CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma
Xu Z, Xu H, Chen X, Huang X, Tian J, Zhao J, Liu B, Shi F, Wu J, Pu J
OncoTargets and Therapy 2023, 16:819-837
Published Date: 18 October 2023
Let-7c-5p Inhibits Cell Proliferation and Migration and Promotes Apoptosis via the CTHRC1/AKT/ERK Pathway in Esophageal Squamous Cell Carcinoma [Retraction]
Zheng Y, Luo M, Lü M, Zhou T, Liu F, Guo X, Zhang J, Kang M
OncoTargets and Therapy 2023, 16:817-818
Published Date: 11 October 2023
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability
Massimino M, Stella S, Tirrò E, Pennisi MS, Stagno F, Vitale SR, Romano C, Tomarchio C, Parrinello NL, Manzella L, Di Raimondo F, Vigneri P
OncoTargets and Therapy 2023, 16:803-816
Published Date: 3 October 2023
Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma [Retraction]
Shen Z, Chai T, Luo F, Liu Z, Xu H, Zhang P, Kang M, Chen S
OncoTargets and Therapy 2023, 16:801-802
Published Date: 29 September 2023
c-Kit Receptors as a Therapeutic Target in Cancer: Current Insights
Abdellateif MS, Bayoumi AK, Mohammed MA
OncoTargets and Therapy 2023, 16:785-799
Published Date: 27 September 2023
Noncoding RNA-Mediated High Expression of PFKFB3 Correlates with Poor Prognosis and Tumor Immune Infiltration of Lung Adenocarcinoma
Gu X, Li X, Zhang X, Tong L, Feng R, Liu L, Sun H, Zhang Q, Bian T, Zhang J, Gao L, Zhang C, Liu J, Liu Y
OncoTargets and Therapy 2023, 16:767-783
Published Date: 22 September 2023
A Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8+T Cell Counts and Age
Wu Y, Liu X, Wang X, Yu L, Yan H, Xie Y, Pu Q, Cai X, Kong Y, Yang Z
OncoTargets and Therapy 2023, 16:753-766
Published Date: 21 September 2023
MicroRNA-145-5p Inhibits Gastric Cancer Invasiveness through Targeting N-Cadherin and ZEB2 to Suppress Epithelial-Mesenchymal Transition [Retraction]
Jiang S, He X, Xia Y, Hu W, Luo J, Zhang J, Tao H
OncoTargets and Therapy 2023, 16:751-752
Published Date: 15 September 2023
MiR-29a Function as Tumor Suppressor in Cervical Cancer by Targeting SIRT1 and Predict Patient Prognosis [Retraction]
Nan P, Niu Y, Wang X, Li Q
OncoTargets and Therapy 2023, 16:749-750
Published Date: 14 September 2023
Lamin B1 Overexpresses in Lung Adenocarcinoma and Promotes Proliferation in Lung Cancer Cells via AKT Pathway [Retraction]
Li W, Li X, Li X, Li M, Yang P, Wang X, Li L, Yang B
OncoTargets and Therapy 2023, 16:747-748
Published Date: 11 September 2023
Long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs [Retraction]
Sun F, Wu K, Yao Z, Mu X, Zheng Z, Sun M, Wang Y, Liu Z, Zhu Y
OncoTargets and Therapy 2023, 16:745-746
Published Date: 11 September 2023
Colon Metastasis from Pancreatic Cancer: A Case Report
Meng N, Han P, Liu L, Liu J, Liu J
OncoTargets and Therapy 2023, 16:739-744
Published Date: 7 September 2023
Recent Advances in the Management of Adverse Events Associated with Lorlatinib
Liao D, Zhang J, Yan T, Chen S, Li W, Shangguan D, She Z
OncoTargets and Therapy 2023, 16:731-738
Published Date: 5 September 2023
MYO5A Inhibition by miR-145 Acts as a Predictive Marker of Occult Neck Lymph Node Metastasis in Human Laryngeal Squamous Cell Carcinoma [Retraction]
Zhao X, Zhang W, Ji W
OncoTargets and Therapy 2023, 16:729-730
Published Date: 5 September 2023
Long Noncoding RNA UCA1 Promotes the Proliferation, Invasion, and Migration of Nasopharyngeal Carcinoma Cells via Modulation of miR-145 [Retraction]
Wu J, Du M, Zhang Q, Zhang W, Fan Y, Yin L, Fei Q, Jiang X, Chen W, Zhu H, Yan P, He X, Bian X
OncoTargets and Therapy 2023, 16:727-728
Published Date: 5 September 2023
Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer [Retraction]
Wang Y, Liu Y, Du X, Ma H, Yao J
OncoTargets and Therapy 2023, 16:725-726
Published Date: 5 September 2023
microRNA-130a is an Oncomir Suppressing the Expression of CRMP4 in Gastric Cancer [Retraction]
Zhou Y, Li R, Yu H, Wang R, Shen Z
OncoTargets and Therapy 2023, 16:723-724
Published Date: 5 September 2023
Chidamide and Oxaliplatin Synergistically Inhibit Colorectal Cancer Growth by Regulating the RPS27A-MDM2-P53 Axis
Li Z, Bu D, Wang X, Zhu L, Lei D, Tang F, Sun X, Chen C, Ji X, Bai S
OncoTargets and Therapy 2023, 16:703-721
Published Date: 30 August 2023
Spotlight on GOT2 in Cancer Metabolism
Kerk SA, Garcia-Bermudez J, Birsoy K, Sherman MH, Shah YM, Lyssiotis CA
OncoTargets and Therapy 2023, 16:695-702
Published Date: 22 August 2023
Circular RNA Circ-Foxo3 Induced Cell Apoptosis in Urothelial Carcinoma via Interaction with miR-191-5p [Retraction]
Wang C, Tao W, Ni S, Chen Q
OncoTargets and Therapy 2023, 16:693-694
Published Date: 11 August 2023
Circular RNA Gprc5a Promotes HCC Progression by Activating YAP1/TEAD1 Signalling Pathway by Sponging miR-1283 [Retraction]
Lin Y, Huang G, Jin H, Jian Z
OncoTargets and Therapy 2023, 16:691-692
Published Date: 11 August 2023
Upregulation of FTX Promotes Osteosarcoma Tumorigenesis by Increasing SOX4 Expression via miR-214-5p [Retraction]
Chen H, Liu T, Ouyang H, Lin S, Zhong H, Zhang H, Yang Y
OncoTargets and Therapy 2023, 16:689-690
Published Date: 10 August 2023
Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights
Chatterjee A, Azevedo-Martins JM, Stachler MD
OncoTargets and Therapy 2023, 16:675-687
Published Date: 10 August 2023
EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction]
Wang C, Li X, Zhang J, Ge Z, Chen H, Hu J
OncoTargets and Therapy 2023, 16:673-674
Published Date: 2 August 2023
Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects
Saida Y, Watanabe S, Kikuchi T
OncoTargets and Therapy 2023, 16:657-671
Published Date: 2 August 2023
Histone Demethylase KDM3A Promotes Cervical Cancer Malignancy Through the ETS1/KIF14/Hedgehog Axis [Retraction]
Liu J, Li D, Zhang X, Li Y, Ou J
OncoTargets and Therapy 2023, 16:655-656
Published Date: 2 August 2023
PVT1 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer via Regulating miR-148/RAB34 Signal Axis [Retraction]
Xi Y, Shen W, Jin C, Wang L, Yu B
OncoTargets and Therapy 2023, 16:653-654
Published Date: 2 August 2023
Long Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating miR-101-3p/STC1 Axis [Retraction]
Luan C, Li Y, Liu Z, Zhao C
OncoTargets and Therapy 2023, 16:651-652
Published Date: 1 August 2023
LncRNA XIST Depletion Prevents Cancer Progression in Invasive Pituitary Neuroendocrine Tumor by Inhibiting bFGF via Upregulation of microRNA-424-5p [Retraction]
Zhou K, Li S, Du G, Fan Y, Wu P, Sun H, Zhang T
OncoTargets and Therapy 2023, 16:649-650
Published Date: 31 July 2023
Long Noncoding RNA SNHG15 Serves as an Oncogene and Predicts Poor Prognosis in Epithelial Ovarian Cancer [Retraction]
Qu C, Dai C, Guo Y, Qin R, Liu J
OncoTargets and Therapy 2023, 16:647-648
Published Date: 26 July 2023
Long Intergenic Non-Protein Coding RNA 519 Promotes the Biological Activities of Tongue Squamous Cell Carcinoma by Sponging microRNA-876-3p and Consequently Upregulating MACC1 [Retraction]
Liu D, Zhao J, Wang H, Li H, Li Y, Qin W
OncoTargets and Therapy 2023, 16:645-646
Published Date: 26 July 2023
lncRNA Differentiation Antagonizing Nonprotein Coding RNA Overexpression Accelerates Progression and Indicates Poor Prognosis in Pancreatic Ductal Adenocarcinoma [Retraction]
Chen L, Liu J, Tang T, Zhang Y, Liu M, Xu L, Zhang J
OncoTargets and Therapy 2023, 16:643-644
Published Date: 26 July 2023
Upregulated miR-27a-3p Indicates a Poor Prognosis in Pancreatic Carcinoma Patients and Promotes the Angiogenesis and Migration by Epigenetic Silencing of GATA6 and Activating VEGFA/VEGFR2 Signaling Pathway [Retraction]
Rao X, Wan L, Jie Z, Zhu X, Yin J, Cao H
OncoTargets and Therapy 2023, 16:641-642
Published Date: 26 July 2023
Long Noncoding RNA NEAT1 Promotes Nasopharyngeal Carcinoma Progression Through Regulation of miR-124/NF-κB Pathway [Retraction]
Cheng N, Guo Y
OncoTargets and Therapy 2023, 16:639-640
Published Date: 26 July 2023
Primary Diffuse Large B-Cell Lymphoma of the Penis: A Case and Literature Review
Yu T, Zou L, Wang Y, Luo C, Yu L
OncoTargets and Therapy 2023, 16:631-638
Published Date: 25 July 2023
Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context
Abdulhaq H, Hwang A, Mahmood O
OncoTargets and Therapy 2023, 16:617-629
Published Date: 20 July 2023
LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma [Retraction]
Wang J, Gao J, Chen Q, Zou W, Yang F, Wei C, Wang Z
OncoTargets and Therapy 2023, 16:615-616
Published Date: 19 July 2023
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers
Parisi A, Rossi F, De Filippis C, Paoloni F, Felicetti C, Mammarella A, Pecci F, Lupi A, Berardi R
OncoTargets and Therapy 2023, 16:585-613
Published Date: 18 July 2023
Identification of Enzalutamide Resistance-Related circRNA-miRNA-mRNA Regulatory Networks in Patients with Prostate Cancer [Retraction]
Yu J, Sun S, Mao W, Xu B, Chen M
OncoTargets and Therapy 2023, 16:583-584
Published Date: 18 July 2023
Long Noncoding RNA ST7-AS1 Upregulates TRPM7 Expression by Sponging microRNA-543 to Promote Cervical Cancer Progression [Retraction]
Qi H, Lu L, Wang L
OncoTargets and Therapy 2023, 16:581-582
Published Date: 13 July 2023
LncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating miR-543-3p/SLC39A10/PTEN Axis in Prostate Cancer [Retraction]
Jia Z, Li W, Bian P, Liu H, Pan D, Dou Z
OncoTargets and Therapy 2023, 16:579-580
Published Date: 13 July 2023
Long Noncoding RNA CCDC144NL-AS1 Promotes the Oncogenicity of Osteosarcoma by Acting as a Molecular Sponge for microRNA-490-3p and Thereby Increasing HMGA2 Expression [Retraction]
He J, Guan J, Liao S, Wu Z, Liu B, Mo H, Yuan Z
OncoTargets and Therapy 2023, 16:577-578
Published Date: 13 July 2023
Gilteritinib Affects the Selection of Dominant Clones in Clonal Hematopoiesis: Sequential Genetic Analysis of an FLT3-ITD Positive AML Patient with Long-Term Gilteritinib Therapy
Katagiri S, Furuya N, Akahane D, Chi S, Minami Y, Harada Y, Harada H, Gotoh A
OncoTargets and Therapy 2023, 16:571-576
Published Date: 12 July 2023
Clinical Utility of Mobocertinib in the Treatment of NSCLC – Patient Selection and Reported Outcomes
Arnold A, Ganti AK
OncoTargets and Therapy 2023, 16:559-569
Published Date: 11 July 2023
Systemic Treatment for Gynecological Cancer Patients Undergoing Hemodialysis
Zhang N, Liu C, Di W
OncoTargets and Therapy 2023, 16:545-558
Published Date: 8 July 2023
The Roles of Serum CXCL16 in Circulating Tregs and Gastrointestinal Stromal Tumor Cells [Retraction]
Xing Y, Zhang J, Xu H
OncoTargets and Therapy 2023, 16:543-544
Published Date: 7 July 2023
Downregulation of Ribophorin II Suppresses Tumor Growth, Migration, and Invasion of Nasopharyngeal Carcinoma [Retraction]
Hong F, Li Y, Ni H, Li J
OncoTargets and Therapy 2023, 16:541-542
Published Date: 7 July 2023
Partial Response to Crizotinib in a Lung Adenocarcinoma Patient with a Novel FBXO11 (Intergenic)-ALK (Exon 20-29) Fusion
He J, Yao Y, Quan F, Lu Z, Wang J, Gao W
OncoTargets and Therapy 2023, 16:535-540
Published Date: 7 July 2023
MACC1 Promotes Angiogenesis in Cholangiocarcinoma by Upregulating VEGFA [Retraction]
Peng T, Li Z, Li D, Wang S
OncoTargets and Therapy 2023, 16:533-534
Published Date: 5 July 2023
Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives
Maher J
OncoTargets and Therapy 2023, 16:515-532
Published Date: 3 July 2023
Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population
Gao M, Li Y, Huang H, Fan Y, Shi R, Su L, Chen C, Li X, Zhu G, Wu D, Cao P, Liu H, Chen J, Kang S
OncoTargets and Therapy 2023, 16:499-513
Published Date: 3 July 2023
miR-141-3p is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma [Retraction]
Wang J, Wang G, Li B, Qiu C, He M
OncoTargets and Therapy 2023, 16:497-498
Published Date: 30 June 2023
A Comprehensive Review of Interventional Clinical Trials in Patients with Bone Metastases
Shen F, Huang J, Yang K, Sun C
OncoTargets and Therapy 2023, 16:485-495
Published Date: 29 June 2023
The Multifunction of miR-218-5p-Cx43 Axis in Breast Cancer [Retraction]
Xia C, Jiang H, Ye F, Zhuang Z
OncoTargets and Therapy 2023, 16:483-484
Published Date: 27 June 2023
PP4R1 Accelerates Cell Growth and Proliferation in HepG2 Hepatocellular Carcinoma [Retraction]
Wu G, Ma Z, Qian J, Liu B
OncoTargets and Therapy 2023, 16:481-482
Published Date: 27 June 2023
Knockdown of Immature Colon Carcinoma Transcript-1 Inhibits Proliferation of Glioblastoma Multiforme Cells through Gap 2/Mitotic Phase Arrest [Retraction]
Xie R, Zhang Y, Shen C, Cao X, Gu S, Che X
OncoTargets and Therapy 2023, 16:479-480
Published Date: 27 June 2023
miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1 [Retraction]
Wang M, Wu Q, Fang M, Huang W, Zhu H
OncoTargets and Therapy 2023, 16:477-478
Published Date: 27 June 2023
miR-139-5p Regulates Proliferation, Apoptosis, and Cell Cycle of Uterine Leiomyoma Cells by Targeting TPD52 [Retraction]
Chen H, Xu H, Meng YG, Zhang Y, Chen JY, Wei XN
OncoTargets and Therapy 2023, 16:475-476
Published Date: 27 June 2023
LOXL1-AS1 Drives the Progression of Gastric Cancer via Regulating miR-142-5p/PIK3CA Axis [Retraction]
Li M, Cai O, Tan S
OncoTargets and Therapy 2023, 16:473-474
Published Date: 26 June 2023
MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Retraction]
Yin Z, Ren W
OncoTargets and Therapy 2023, 16:471-472
Published Date: 23 June 2023
Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report
Iso H, Miyanaga A, Kadoma N, Shinbu K, Tozuka T, Murata A, Nishima S, Sato Y, Nakamichi S, Matsumoto M, Noro R, Terasaki Y, Kubota K, Seike M
OncoTargets and Therapy 2023, 16:465-470
Published Date: 23 June 2023
Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives
Shrivastava T, Van Rhee F, Al Hadidi S
OncoTargets and Therapy 2023, 16:441-464
Published Date: 20 June 2023
Esomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells
Duan J, Zhang Z, Du J, Zhang J, Li M, Li C
OncoTargets and Therapy 2023, 16:425-440
Published Date: 20 June 2023
The Important Tumor Suppressor Role of PER1 in Regulating the Cyclin–CDK–CKI Network in SCC15 Human Oral Squamous Cell Carcinoma Cells [Retraction]
Fu X, Li H, Yang K, Chen D, Tang H
OncoTargets and Therapy 2023, 16:423-424
Published Date: 19 June 2023
MicroRNA 628 Suppresses Migration and Invasion of Breast Cancer Stem Cells through Targeting SOS1 [Retraction]
Lin C, Gao B, Yan X, Lei Z, Chen K, Li Y, Zeng Q, Chen Z, Li H
OncoTargets and Therapy 2023, 16:421-422
Published Date: 19 June 2023
Single-Center Retrospective Clinical Evaluation of Venetoclax Combined with HMAs and Half-Dose CAG for Unfit or Refractory/Relapsed AML
Chen X, Zhao Y, Li Q, Fan S
OncoTargets and Therapy 2023, 16:409-419
Published Date: 13 June 2023
CCDC7 Activates Interleukin-6 and Vascular Endothelial Growth Factor to Promote Proliferation via the JAK-STAT3 Pathway in Cervical Cancer Cells [Retraction]
Zhou C, He X, Zeng Q, Zhang P, Wang C
OncoTargets and Therapy 2023, 16:407-408
Published Date: 9 June 2023
Low-Grade Ductal Carcinoma in situ Within a Fibroadenoma of the Breast: A Rare Case Report and Review of the Literature
Ni XH, An R, Shi QW, Wang CL
OncoTargets and Therapy 2023, 16:399-406
Published Date: 9 June 2023
Immunotherapy Plus Radiotherapy for the Treatment of Sarcomas: Is There a Potential for Synergism?
Wang J, Ge H, Tian Z
OncoTargets and Therapy 2023, 16:385-397
Published Date: 7 June 2023
Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers
D'Avola A, Kluckova K, Finch AJ, Riches JC
OncoTargets and Therapy 2023, 16:371-383
Published Date: 7 June 2023
Targeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab
El-ghazzi N, Durando X, Giro A, Herrmann T
OncoTargets and Therapy 2023, 16:359-369
Published Date: 2 June 2023
JUND Promotes Tumorigenesis via Specifically Binding on Enhancers of Multiple Oncogenes in Cervical Cancer
Zhou J, Mo J, Tan C, Xie F, Liang J, Huang W
OncoTargets and Therapy 2023, 16:347-357
Published Date: 31 May 2023
High Expression of Triggering Receptor Expressed on Myeloid Cells 1 Predicts Poor Prognosis in Glioblastoma
Ma K, Guo Q, Zhang X, Li Y
OncoTargets and Therapy 2023, 16:331-345
Published Date: 29 May 2023
LINC00958 Promotes the Malignancy of Nasopharyngeal Carcinoma by Sponging microRNA-625 and Thus Upregulating NUAK1 [Retraction]
Chen M, Xu Z, Zhang Y, Zhang X
OncoTargets and Therapy 2023, 16:329-330
Published Date: 26 May 2023
Circ_0005576 Promotes Malignant Progression Through miR-874/CDK8 Axis in Colorectal Cancer [Retraction]
Yu C, Li S, Hu X
OncoTargets and Therapy 2023, 16:327-328
Published Date: 18 May 2023
The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib
Chen KC, Huang YH, Hsu KH, Tseng JS, Chang GC, Yang TY
OncoTargets and Therapy 2023, 16:317-326
Published Date: 17 May 2023
KDM5C Expedites Lung Cancer Growth and Metastasis Through Epigenetic Regulation of MicroRNA-133a [Retraction]
Zhang Q, Xu L, Wang J, Zhu X, Ma Z, Yang J, Li J, Jia X, Wei L
OncoTargets and Therapy 2023, 16:315-316
Published Date: 15 May 2023
LINC00565 Enhances Proliferative Ability in Endometrial Carcinoma by Downregulating KLF9 [Retraction]
Yin X, Li X, Feng G, Qu Y, Wang H
OncoTargets and Therapy 2023, 16:313-314
Published Date: 15 May 2023
MicroRNA-381 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma by Targeting X-Linked Inhibitor of Apoptosis Protein [Retraction]
Zhou S, Cui Y, Yu D, Liang J, Zhang M, Ye W
OncoTargets and Therapy 2023, 16:311-312
Published Date: 11 May 2023
KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo [Retraction]
Yang GH, Ren ZX, Yang X, Zhang YG
OncoTargets and Therapy 2023, 16:309-310
Published Date: 9 May 2023
Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin
Wijnen NE, Koedijk JB, Klein K, Luesink M, Goemans BF, Zwaan CM, Kaspers GJL
OncoTargets and Therapy 2023, 16:297-308
Published Date: 29 April 2023
MNK Proteins as Therapeutic Targets in Leukemia
Mazewski C, Platanias LC
OncoTargets and Therapy 2023, 16:283-295
Published Date: 21 April 2023
LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction]
Song X, Xu X, Ren X, Ruan X, Wang Y, Yao TT
OncoTargets and Therapy 2023, 16:281-282
Published Date: 21 April 2023
Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers [Corrigendum]
Ma DN, Gao XY, Dan YB, Zhang AN, Wang WJ, Yang G, Zhu HZ
OncoTargets and Therapy 2023, 16:279-280
Published Date: 20 April 2023
Resveratrol Reverses Cigarette Smoke-Induced Urocystic Epithelial–Mesenchymal Transition via Suppression of STAT3 Phosphorylation in SV-HUC-1-Immortalized Human Urothelial Cells [Retraction]
Sun H, Zhang Z, Zhang T, Geng H, Xie D, Wang Y, Ding D, Zhang T, Yu D
OncoTargets and Therapy 2023, 16:277-278
Published Date: 18 April 2023
Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction]
Tan T, Chen J, Hu Y, Wang N, Chen Y, Yu T, Lin D, Yang S, Luo J, Luo X
OncoTargets and Therapy 2023, 16:275-276
Published Date: 12 April 2023
Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma
Hamai Y, Emi M, Ibuki Y, Kurokawa T, Yoshikawa T, Ohsawa M, Hirohata R, Kitasaki N, Okada M
OncoTargets and Therapy 2023, 16:263-273
Published Date: 10 April 2023
miR-302 Cluster Inhibits Angiogenesis and Growth of K562 Leukemia Cells by Targeting VEGFA [Retraction]
Cao J, Li L, Han X, Cheng H, Chen W, Qi K, Chen C, Wu Q, Niu M, Zeng L, Xu K
OncoTargets and Therapy 2023, 16:261-262
Published Date: 8 April 2023
Minimal Residual Disease Monitoring in Radically Treated Non-Small Cell Lung Cancer: Challenges and Future Directions
O'Sullivan HM, Feber A, Popat S
OncoTargets and Therapy 2023, 16:249-259
Published Date: 7 April 2023
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far
Stella S, Martorana F, Massimino M, Vitale SR, Manzella L, Vigneri P
OncoTargets and Therapy 2023, 16:235-247
Published Date: 7 April 2023
MicroRNA-143-3p Suppresses Tumorigenesis by Targeting Catenin-δ1 in Colorectal Cancer [Retraction]
Ding X, Du J, Mao K, Wang X, Ding Y, Wang F
OncoTargets and Therapy 2023, 16:233-234
Published Date: 6 April 2023
From Co-Stimulation to Co-Inhibition: A Continuum of Immunotherapy Care Toward Long-Term Survival in Melanoma
Simonetti E, Cutarella S, Valente M, Sani T, Ravara M, Maio M, Di Giacomo AM
OncoTargets and Therapy 2023, 16:227-232
Published Date: 5 April 2023
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
Badiginchala R, Dattatreya PS, Suresh AVS, Nirni SS, Andra VV, Bunger D, Chaturvedi A
OncoTargets and Therapy 2023, 16:215-225
Published Date: 1 April 2023
Matrine Suppresses the Migration and Invasion of NSCLC Cells by Inhibiting PAX2-Induced Epithelial-Mesenchymal Transition [Retraction]
Yang J, He D, Peng Y, Zhong HZ, Deng YH, Yu Z, Guan C, Zuo Y, Xu Z
OncoTargets and Therapy 2023, 16:213-214
Published Date: 29 March 2023
CXCL8 Promotes Glioma Progression by Activating the JAK/STAT1/HIF-1α/Snail Signaling Axis [Retraction]
Chen Z, Mou L, Pan Y, Feng C, Zhang J, Li J
OncoTargets and Therapy 2023, 16:211-212
Published Date: 28 March 2023
Transmission of Exosomal TPX2 Promotes Metastasis and Resistance of NSCLC Cells to Docetaxel
Hu J, He Q, Tian T, Chang N, Qian L
OncoTargets and Therapy 2023, 16:197-210
Published Date: 27 March 2023
Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date
Varella L, Cristofanilli M
OncoTargets and Therapy 2023, 16:189-196
Published Date: 23 March 2023
Role of Systemic Immunoinflammation Landscape in the Overall Survival of Patients with Leptomeningeal Metastases from Lung Cancer
Wang JW, Yuan Q, Li L, Cao KH, Liu Q, Wang HL, Hu K, Wu X, Wan JH
OncoTargets and Therapy 2023, 16:179-187
Published Date: 23 March 2023
Portulacerebroside a Inhibits Adhesion, Migration, and Invasion of Human Leukemia HL60 Cells and U937 Cells through the Regulation of p38/JNK Signaling Pathway [Retraction]
Ye QD, Liao XL, Fu P, Dou JY, Chen K, Jiang H
OncoTargets and Therapy 2023, 16:177-178
Published Date: 16 March 2023
A Review of CAR-T Therapy in Pediatric and Young Adult B-Lineage Acute Leukemia: Clinical Perspectives in Singapore
Seng MS, Meierhofer AC, Lim FL, Soh SY, Hwang WYK
OncoTargets and Therapy 2023, 16:165-176
Published Date: 14 March 2023
Clinical Efficacy and Safety of Immunotherapy Retreatment in Metastatic Cervical Cancer: A Retrospective Study
Li G, Cheng M, Hong K, Jiang Y
OncoTargets and Therapy 2023, 16:157-163
Published Date: 6 March 2023
Biochemical Origin of the Warburg Effect in Light of 15 Years of Research Experience: A Novel Evidence-Based View (An Expert Opinion Article)
El Sayed SM
OncoTargets and Therapy 2023, 16:143-155
Published Date: 5 March 2023
Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect [Corrigendum]
Yan X, Liu SM, Liu C
OncoTargets and Therapy 2023, 16:141-142
Published Date: 1 March 2023
Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report
Alanzi M, Abu-Tineh M, Szabados L, Sharaf Eldean M, Alatasi S, Taha RY, Elkourashy SA
OncoTargets and Therapy 2023, 16:133-139
Published Date: 21 February 2023
HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks
Mandó P, Waisberg F, Pasquinelli R, Rivero S, Ostinelli A, Perazzo F
OncoTargets and Therapy 2023, 16:115-132
Published Date: 19 February 2023
Ineffectiveness of Crizotinib in a Non-Small-Cell Lung Cancer with Novel ALK- LIMS1 Fusion: A Case Report
Shi J, Jia Z, Zhou Z, Zhao L, Meng Q, Liu Y
OncoTargets and Therapy 2023, 16:109-114
Published Date: 17 February 2023
Neoadjuvant PD-1 Blockade in Non-Small Cell Lung Cancer: Current perspectives and Moving Forward
Shinada K, Murakami S
OncoTargets and Therapy 2023, 16:99-108
Published Date: 15 February 2023
Secondary Sinonasal Collision Tumor of Papillary Squamous Cell Carcinoma and Small Cell Neuroendocrine Carcinoma After Nasopharyngeal Carcinoma Radiotherapy: A Case Report and Literature Review of Sinonasal Collision Carcinomas
Tang H, Wang L, Xu W, Xu Y, Li X, Guo D
OncoTargets and Therapy 2023, 16:91-97
Published Date: 11 February 2023
Successful Retreatment with Crizotinib After Crizotinib-Induced Liver Failure in ALK-Positive Advanced Lung Adenocarcinoma: A Case Report
Zhang X, Ni K, Chen H
OncoTargets and Therapy 2023, 16:87-90
Published Date: 25 January 2023
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects
Pineda E, Domenech M, Hernández A, Comas S, Balaña C
OncoTargets and Therapy 2023, 16:71-86
Published Date: 25 January 2023
Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report
Misawa K, Nakamichi S, Iida H, Nagano A, Mikami E, Tozuka T, Matsumoto M, Miyanaga A, Noro R, Kubota K, Yamaguchi H, Seike M
OncoTargets and Therapy 2023, 16:65-69
Published Date: 24 January 2023
Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma: Current Landscape and Future Direction
Buller DM, Antony M, Ristau BT
OncoTargets and Therapy 2023, 16:49-64
Published Date: 24 January 2023
miR-497 Inhibited Proliferation, Migration and Invasion of Thyroid Papillary Carcinoma Cells by Negatively Regulating YAP1 Expression [Retraction]
Cheng H, Dong H, Feng J, Tian H, Zhang H, Xu L
OncoTargets and Therapy 2023, 16:47-48
Published Date: 19 January 2023
FMS-Like Tyrosine Kinase 3 Inhibitors in the Treatment of Acute Myeloid Leukemia: An Update on the Emerging Evidence and Safety Profile
Garciaz S, Hospital MA
OncoTargets and Therapy 2023, 16:31-45
Published Date: 19 January 2023
A Refractory Case of CDKN2A/B Loss Metastatic Intrahepatic Cholangiocarcinoma Achieving a Partial Response After First-Line Treatment with Palbociclib
Fan W, Wang C, Zhong X, Zheng Y, Chen T, Huang M, Su S
OncoTargets and Therapy 2023, 16:23-29
Published Date: 19 January 2023
A Primary Lung and Breast Cancer Patient with Germline EGFR R776H Mutation: A Case Report and Literature Review
Li D, Liu X, Cui S, Yang D, Zhu Y, Pan E, Yang P, Dai Z
OncoTargets and Therapy 2023, 16:17-22
Published Date: 18 January 2023
Post-Hematopoietic Cell Transplantation Relapsed Acute Lymphoblastic Leukemia: Current Challenges and Future Directions
Varadarajan I, Pierce E, Scheuing L, Morris A, El Chaer F, Keng M
OncoTargets and Therapy 2023, 16:1-16
Published Date: 14 January 2023